Evaluation of encapsulating and microporous nondegradable hydrogel scaffold designs on islet engraftment in rodent models of diabetes. Issue 9 (25th June 2018)

• Record Type: Journal Article
• Authors: Rios, Peter D.; Skoumal, Michael; Liu, Jeffrey; Youngblood, Richard; Kniazeva, Ekaterina; Garcia, Andrés J.; Shea, Lonnie D.
• Is Part Of: Biotechnology and bioengineering. Volume 115:Issue 9(2018)
• Page Start: 2356
• Page End: 2364
• Publication Date: 2018-06-25
• Subjects: Encapsulating -- hydrogel -- microporous -- polyethylene glycol (PEG); Biotechnology -- Periodicals; Bioengineering -- Periodicals; 660.6
• DOI: 10.1002/bit.26741
• Languages: English
• ISSNs: 0006-3592

Abstract

Abstract: Islet transplantation is a promising therapeutic option for type 1 diabetes mellitus, yet the current delivery into the hepatic portal vasculature is limited by poor engraftment. Biomaterials have been used as a means to promote engraftment and function at extrahepatic sites, with strategies being categorized as encapsulation or microporous scaffolds that can either isolate or integrate islets with the host tissue, respectively. Although these approaches are typically studied separately using distinct material platforms, herein, we developed nondegradable polyethylene glycol (PEG)‐based hydrogels for islet encapsulation or as microporous scaffolds for islet seeding to compare the initial engraftment and function of islets in syngeneic diabetic mice. Normoglycemia was restored with transplantation of islets within either encapsulating or microporous hydrogels containing 700 islet equivalents (IEQ), with transplantation on microporous hydrogels producing lower blood glucose levels at earlier times. A glucose challenge test at 1 month after transplant indicated that encapsulated islets had a delay in glucose‐stimulated insulin secretion, whereas microporous hydrogels restored normoglycemia in times consistent with native pancreata. Encapsulated islets remained isolated from the host tissue, whereas the microporous scaffolds allowed for revascularization of the islets after transplant. Finally, we compared the inflammatory response after transplantation for the two systems and noted that microporous hydrogels had a substantially increased presence of neutrophils. Collectively, these findings suggest that both encapsulation and microporous PEG scaffold designs allow for stable engraftment of syngeneic islets and the ability to restore normoglycemia, yet the architecture influences islet function and responsiveness after transplantation. Abstract : Non‐degradable PEG hydrogels were developed for islet encapsulation or islet seeding to compare engraftment. Using a syngeneic rodent model of diabetes, normoglycemia was restored using either encapsulating or microporous scaffolds containing 700 islet equivalent, with microporous hydrogels achieving lower blood glucose levels at earlier time points. Characterization of the inflammatory response demonstrated microporous scaffolds had a substantially increased presence of neutrophils. These studies confirm both scaffold designs allow for engraftment, yet the architecture influences islet function and responsiveness post‐transplantation.